Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLIADEL Wafer in Metastatic Brain Cancer
NCT00525590Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Dec 2007
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of polifeprosan 20 in brain cancer, sponsored by Eisai Co., Ltd.. Started Dec 2007; status: completed.
02
Drugs
polifeprosan 20
03
Conditions
brain cancer
Beyond the preview
Go deeper on NCT00525590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00525590.